type here...

CATEGORIES

Healthcare

LATEST

1...747576Page 76 of 76

TRENDING

EDITORS CHOICE

“Investigational” Is Payer Code for “Coverage Denied”

Gil Bashe, Medika Life Editor -
Outside the pandemic, “investigational” remains payer code for denying reimbursement. In the case of treatment for chronic conditions, even FDA-approved digital-health and connected devices languish on waitlists for formulary inclusion.

Theranos’ Biggest Crime is Casting Doubt on Consumer Diagnostics

Gil Bashe, Medika Life Editor -
One casualty of the Theranos scandal is that the idea of convenient, more accessible, diagnostic blood tests. We need great, consumer-focused, diagnostic care that lead to definitive answers around patients’ risk of disease and the ability to stay on top of chronic conditions.

Mindray’s New POC Ultrasound System Redefines What’s Possible

Medika Life -
The ME8 System's main unit is one of the lightest and thinnest laptop-based ultrasound machines in the industry.

Does Pharma Need Independent DNA Oversight?

Robert Turner, Founding Editor -
Our survival as a species could be placed in jeopardy if we don't begin to police treatments that place our DNA in harms way. Oversight is needed.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories